Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conversion from mycophenolate mofetil to domestic enteric-coated mycophenolate sodium in stable kidney transplant recipients
ChiCTR2400091632Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Xi'an Jiaotong University
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of mycophenolate sodium in Kidney transplant recipient care, sponsored by First Affiliated Hospital of Xi'an Jiaotong University. Primary endpoint: Gastrointestinal symptom score. Started Oct 2024; status: recruiting.
02
Drugs
mycophenolate sodium
03
Conditions
Kidney transplant recipient care
Beyond the preview
Go deeper on ChiCTR2400091632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400091632.